Terasaki Institute for Biomedical Innovation: Justin Chen Li

Helio Genomics CEO Justin Chen Li has been invited to the leadership board of the Terasaki Institute for Biomedical Innovation at the University of California, Los Angeles. The board serves as an advisory group for the institute, which aims to invent and foster practical solutions to restore or enhance individuals' health.